跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 351 条关于
“VP4”
全部
351
临床试验
207
药物
121
机构
1
资讯
22
2个月前
Porcine Rotavirus Vaccines Face a Cross-Protection Gap as Reassortant Strains Emerge
11个月前
ONO-4578 EP4 Antagonist Combination Shows Significant PFS Improvement in Advanced Gastric Cancer
去年
Nxera Pharma Advances Novel EP4 Antagonist HTL0039732 to Phase 2a Trial for Advanced Solid Tumors
3个月前
Genentech Lays Off 103 Employees in Fifth Round of Cuts Since Mid-2025, Three VPs Among Casualties
2年前
Nxera and Cancer Research UK Presenting Phase 1/2a Trial of EP4 Antagonist HTL0039732 at ESMO 2024
6个月前
Kainova Therapeutics Reports Positive Phase I Results for Oral EP4 Receptor Antagonist DT-9081 in Advanced Solid Tumors
7个月前
Immunocore Restructures R&D Leadership as Executive VP Berman Departs
11个月前
iMDx Appoints Marketing VP to Spearhead Commercial Launch of Transplant Rejection Diagnostic
去年
Ascentage Pharma Strengthens Leadership Team with New CFO and Senior VP Appointments
2年前
VP-315 Demonstrates Tumor Reduction in Basal Cell Carcinoma Phase 2 Trial
第 1 页,共 3 页
上一页
下一页